{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apoptosis", "cancer therapy", "inflammation", "myricetin", "signal transduction pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37298616", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "12"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "02"}], "Language": ["eng"], "ELocationID": ["9665", "10.3390/ijms24119665"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "11", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "02"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways.", "Abstract": {"AbstractText": ["Cancer is a major public health concern worldwide and main burden of the healthcare system. Regrettably, most of the currently used cancer treatment approaches such as targeted therapy, chemotherapy, radiotherapy and surgery usually cause adverse complications including hair loss, bone density loss, vomiting, anemia and other complications. However, to overcome these limitations, there is an urgent need to search for the alternative anticancer drugs with better efficacy as well as less adverse complications. Based on the scientific evidences, it is proven that naturally occurring antioxidants present in medicinal plants or their bioactive compounds might constitute a good therapeutic approach in diseases management including cancer. In this regard, myricetin, a polyhydroxy flavonol found in a several types of plants and its role in diseases management as anti-oxidant, anti-inflammatory and hepato-protective has been documented. Moreover, its role in cancer prevention has been noticed through modulation of angiogenesis, inflammation, cell cycle arrest and induction of apoptosis. Furthermore, myricetin plays a significant role in cancer prevention through the inhibition of inflammatory markers such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (Cox-2). Moreover, myricetin increases the chemotherapeutic potential of other anticancer drugs through modulation of cell signaling molecules activity. This review elaborates the information of myricetin role in cancer management through modulating of various cell-signaling molecules based on in vivo and in vitro studies. In addition, synergistic effect with currently used anticancer drugs and approaches to improve bioavailability are described. The evidences collected in this review will help different researchers to comprehend the information about its safety aspects, effective dose for different cancers and implication in clinical trials. Moreover, different challenges need to be focused on engineering different nanoformulations of myricetin to overcome the poor bioavailability, loading capacity, targeted delivery and premature release of this compound. Furthermore, some more derivatives of myricetin need to be synthesized to check their anticancer potential."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Rahmani", "ForeName": "Arshad Husain", "Initials": "AH"}, {"Identifier": ["0000-0002-1491-6402"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Almatroudi", "ForeName": "Ahmad", "Initials": "A"}, {"Identifier": ["0000-0002-6486-9835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Allemailem", "ForeName": "Khaled S", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Alwanian", "ForeName": "Wanian M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Alharbi", "ForeName": "Basmah F", "Initials": "BF"}, {"Identifier": ["0000-0002-0850-5500"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Alrumaihi", "ForeName": "Faris", "Initials": "F"}, {"Identifier": ["0000-0001-6030-4493"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Amjad Ali", "Initials": "AA"}, {"Identifier": ["0000-0002-5260-0265"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Almatroodi", "ForeName": "Saleh A", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "76XC01FTOJ", "NameOfSubstance": "myricetin"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}], "CoiStatement": "The authors declare no conflict of interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Matthews H.K., Bertoli C., de Bruin R.A.M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 2022;23:74\u201388. doi: 10.1038/s41580-021-00404-3.", "ArticleIdList": ["10.1038/s41580-021-00404-3", "34508254"]}, {"Citation": "Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346. doi: 10.1158/2159-8290.CD-21-1059.", "ArticleIdList": ["10.1158/2159-8290.CD-21-1059", "35022204"]}, {"Citation": "Zhang C.-L., Huang T., Wu B.-L., He W.-X., Liu D. Stem cells in cancer therapy: Opportunities and challenges. Oncotarget. 2017;8:75756\u201375766. doi: 10.18632/oncotarget.20798.", "ArticleIdList": ["10.18632/oncotarget.20798", "PMC5650462", "29088907"]}, {"Citation": "Ayob A.Z., Ramasamy T.S. Cancer stem cells as key drivers of tumour progression. J. Biomed. Sci. 2018;25:20. doi: 10.1186/s12929-018-0426-4.", "ArticleIdList": ["10.1186/s12929-018-0426-4", "PMC5838954", "29506506"]}, {"Citation": "Adel N. Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. Am. J. Manag. Care. 2017;23:S259\u2013S265.", "ArticleIdList": ["28978206"]}, {"Citation": "Seca A.M.L., Pinto D.C.G.A. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int. J. Mol. Sci. 2018;19:263. doi: 10.3390/ijms19010263.", "ArticleIdList": ["10.3390/ijms19010263", "PMC5796209", "29337925"]}, {"Citation": "Mishra B.B., Tiwari V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011;46:4769\u20134807. doi: 10.1016/j.ejmech.2011.07.057.", "ArticleIdList": ["10.1016/j.ejmech.2011.07.057", "21889825"]}, {"Citation": "Almatroodi S.A., AAlsahli M., SMAljohani A., Alhumaydhi F.A., Babiker A.Y., Khan A.A., Rahmani A.H. Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer. Molecules. 2022;27:2665. doi: 10.3390/molecules27092665.", "ArticleIdList": ["10.3390/molecules27092665", "PMC9101422", "35566016"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Rahmani A.H. Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways. Anti-Cancer Agents Med. Chem. 2019;19:1314\u20131324. doi: 10.2174/1871520619666190409100955.", "ArticleIdList": ["10.2174/1871520619666190409100955", "30963982"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Khan A.A., Rahmani A.H. Peppermint,(Mentha \u00d7 piperita): Role in Management of Diseases through Modulating Various Biological Activities. Pharmacogn. J. 2021;13:822\u2013827. doi: 10.5530/pj.2021.13.104.", "ArticleIdList": ["10.5530/pj.2021.13.104"]}, {"Citation": "Rahmani A.H., Alsahli M.A., Almatroodi S.A. Potential antitumor effects of pomegranates and its ingredients. Pharmacogn. Rev. 2017;11:136\u2013140. doi: 10.4103/phrev.phrev_25_17.", "ArticleIdList": ["10.4103/phrev.phrev_25_17", "PMC5628519", "28989248"]}, {"Citation": "Mansouri K., Rasoulpoor S., Daneshkhah A., Abolfathi S., Salari N., Mohammadi M., Rasoulpoor S., Shabani S. Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020;20:791. doi: 10.1186/s12885-020-07256-8.", "ArticleIdList": ["10.1186/s12885-020-07256-8", "PMC7446227", "32838749"]}, {"Citation": "Cheng Z., Zhang Z., Han Y., Wang J., Wang Y., Chen X., Shao Y., Cheng Y., Zhou W., Lu X., et al. A review on anti-cancer effect of green tea catechins. J. Funct. Foods. 2020;74:104172. doi: 10.1016/j.jff.2020.104172.", "ArticleIdList": ["10.1016/j.jff.2020.104172"]}, {"Citation": "Lv Z.-D., Liu X.-P., Zhao W.-J., Dong Q., Li F.-N., Wang H.-B., Kong B. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. Int. J. Clin. Exp. Pathol. 2014;7:2818\u20132824.", "ArticleIdList": ["PMC4097278", "25031701"]}, {"Citation": "Bonofiglio D., Giordano C., De Amicis F., Lanzino M., Ando S. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets. Mini Rev. Med. Chem. 2016;16:596\u2013604. doi: 10.2174/1389557515666150709110959.", "ArticleIdList": ["10.2174/1389557515666150709110959", "26156544"]}, {"Citation": "Sultana B., Anwar F. Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food Chem. 2008;108:879\u2013884. doi: 10.1016/j.foodchem.2007.11.053.", "ArticleIdList": ["10.1016/j.foodchem.2007.11.053", "26065748"]}, {"Citation": "Jahan N., Khalil-Ur-Rahman A.S., Asi M.R. Phenolic acid and flavonol contents of gemmo-modified and native extracts of some indigenous medicinal plants. Pak. J. Bot. 2013;45:1515\u20131519."}, {"Citation": "Mustafa R., Hamid A.A., Mohamed S., Abu Bakar F. Total Phenolic Compounds, Flavonoids, and Radical Scavenging Activity of 21 Selected Tropical Plants. J. Food Sci. 2010;75:C28\u2013C35. doi: 10.1111/j.1750-3841.2009.01401.x.", "ArticleIdList": ["10.1111/j.1750-3841.2009.01401.x", "20492146"]}, {"Citation": "H\u00e4kkinen S.H., K\u00e4renlampi S.O., Heinonen I.M., Mykk\u00e4nen H.M., T\u00f6rr\u00f6nen A.R. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J. Agric. Food Chem. 1999;47:2274\u20132279. doi: 10.1021/jf9811065.", "ArticleIdList": ["10.1021/jf9811065", "10794622"]}, {"Citation": "Ozcan C., Yaman M. Determination of Myricetin in Medicinal Plants by High-Performance Liquid Chromatography. Instrum. Sci. Technol. 2014;43:44\u201352. doi: 10.1080/10739149.2014.940533.", "ArticleIdList": ["10.1080/10739149.2014.940533"]}, {"Citation": "Sarker U., Oba S. Antioxidant constituents of three selected red and green color Amaranthus leafy vegetable. Sci. Rep. 2019;9:18233. doi: 10.1038/s41598-019-52033-8.", "ArticleIdList": ["10.1038/s41598-019-52033-8", "PMC6890792", "31796754"]}, {"Citation": "Nardini M., Garaguso I. Characterization of bioactive compounds and antioxidant activity of fruit beers. Food Chem. 2020;305:125437. doi: 10.1016/j.foodchem.2019.125437.", "ArticleIdList": ["10.1016/j.foodchem.2019.125437", "31499290"]}, {"Citation": "Barzegar A. Antioxidant activity of polyphenolic myricetin in vitro cell-free and cell-based systems. Mol. Biol. Res. Commun. 2016;5:87\u201395. doi: 10.22099/MBRC.2016.3651.", "ArticleIdList": ["10.22099/MBRC.2016.3651", "PMC5219898", "28097162"]}, {"Citation": "Grenier D., Chen H., Ben Lagha A., Fournier-Larente J., Morin M.-P. Dual Action of Myricetin on Porphyromonas gingivalis and the Inflammatory Response of Host Cells: A Promising Therapeutic Molecule for Periodontal Diseases. PLoS ONE. 2015;10:e0131758. doi: 10.1371/journal.pone.0131758.", "ArticleIdList": ["10.1371/journal.pone.0131758", "PMC4487256", "26121135"]}, {"Citation": "Lv H., An B., Yu Q., Cao Y., Liu Y., Li S. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis. Int. J. Biol. Macromol. 2020;155:1092\u20131104. doi: 10.1016/j.ijbiomac.2019.11.075.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.11.075", "31712142"]}, {"Citation": "Hussain S.P., Harris C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer. 2007;121:2373\u20132380. doi: 10.1002/ijc.23173.", "ArticleIdList": ["10.1002/ijc.23173", "17893866"]}, {"Citation": "Devi K.P., Rajavel T., Habtemariam S., Nabavi S.M. Molecular mechanisms underlying anticancer effects of myricetin. Life Sci. 2015;142:19\u201325. doi: 10.1016/j.lfs.2015.10.004.", "ArticleIdList": ["10.1016/j.lfs.2015.10.004", "26455550"]}, {"Citation": "Afroze N., Pramodh S., Hussain A., Waleed M., Vakharia K. A review on myricetin as a potential therapeutic candidate for cancer prevention. 3 Biotech. 2020;10:1\u201312. doi: 10.1007/s13205-020-02207-3.", "ArticleIdList": ["10.1007/s13205-020-02207-3", "PMC7181463", "32351869"]}, {"Citation": "Jiang M., Zhu M., Wang L., Yu S. Anti-tumor effects and associated molecular mechanisms of myricetin. Biomed. Pharmacother. 2019;120:109506. doi: 10.1016/j.biopha.2019.109506.", "ArticleIdList": ["10.1016/j.biopha.2019.109506", "31586904"]}, {"Citation": "Song X., Tan L., Wang M., Ren C., Guo C., Yang B., Ren Y., Cao Z., Li Y., Pei J. Myricetin: A review of the most recent research. Biomed. Pharmacother. 2021;134:111017. doi: 10.1016/j.biopha.2020.111017.", "ArticleIdList": ["10.1016/j.biopha.2020.111017", "33338751"]}, {"Citation": "Lau-Cam C.A., Chan H. Flavonoids from Comptonia peregrina. Phytochemistry. 1973;12:1829. doi: 10.1016/0031-9422(73)80420-0.", "ArticleIdList": ["10.1016/0031-9422(73)80420-0"]}, {"Citation": "Jones J.R., Lebar M.D., Jinwal U.K., Abisambra J.F., Koren J., Blair L., 3rd, O\u2019Leary J.C., Davey Z., Trotter J., Johnson A.G., et al. The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. J. Nat. Prod. 2011;74:38\u201344. doi: 10.1021/np100572z.", "ArticleIdList": ["10.1021/np100572z", "PMC3070757", "21141876"]}, {"Citation": "Ross J.A., Kasum C.M. DIETARY FLAVONOIDS: Bioavailability, Metabolic Effects, and Safety. Annu. Rev. Nutr. 2002;22:19\u201334. doi: 10.1146/annurev.nutr.22.111401.144957.", "ArticleIdList": ["10.1146/annurev.nutr.22.111401.144957", "12055336"]}, {"Citation": "Harris T., Jideani V., Roes-Hill M.L. Flavonoids and tannin composition of Bambara groundnut (Vigna subterranea) of Mpuma-langa, South Africa. Heliyon. 2018;4:e00833. doi: 10.1016/j.heliyon.2018.e00833.", "ArticleIdList": ["10.1016/j.heliyon.2018.e00833", "PMC6168962", "30294697"]}, {"Citation": "Ali M.C., Chen J., Zhang H., Li Z., Zhao L., Qiu H. Effective extraction of flavonoids from Lycium barbarum L. fruits by deep eutectic solvents-based ultrasound-assisted extraction. Talanta. 2019;203:16\u201322. doi: 10.1016/j.talanta.2019.05.012.", "ArticleIdList": ["10.1016/j.talanta.2019.05.012", "31202321"]}, {"Citation": "Miean K.H., Mohamed S. Flavonoid (Myricetin, Quercetin, Kaempferol, Luteolin, and Apigenin) Content of Edible Tropical Plants. J. Agric. Food Chem. 2001;49:3106\u20133112. doi: 10.1021/jf000892m.", "ArticleIdList": ["10.1021/jf000892m", "11410016"]}, {"Citation": "Sahoo D.K., Borcherding D.C., Chandra L., Jergens A.E., Atherly T., Bourgois-Mochel A., Ellinwood N.M., Snella E., Severin A.J., Martin M., et al. Differential transcriptomic profiles following stimulation with lipopolysaccharide in intestinal or-ganoids from dogs with inflammatory bowel disease and intestinal mast cell tumor. Cancers. 2022;14:3525. doi: 10.3390/cancers14143525.", "ArticleIdList": ["10.3390/cancers14143525", "PMC9322748", "35884586"]}, {"Citation": "Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis. 2009;30:1073\u20131081. doi: 10.1093/carcin/bgp127.", "ArticleIdList": ["10.1093/carcin/bgp127", "19468060"]}, {"Citation": "Lin W.-W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 2007;117:1175\u20131183. doi: 10.1172/JCI31537.", "ArticleIdList": ["10.1172/JCI31537", "PMC1857251", "17476347"]}, {"Citation": "Maeda H., Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry. 1998;63:854\u2013865.", "ArticleIdList": ["9721338"]}, {"Citation": "Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer. 2004;4:71\u201378. doi: 10.1038/nrc1256.", "ArticleIdList": ["10.1038/nrc1256", "14708027"]}, {"Citation": "Greten F.R., Grivennikov S.I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019;51:27\u201341. doi: 10.1016/j.immuni.2019.06.025.", "ArticleIdList": ["10.1016/j.immuni.2019.06.025", "PMC6831096", "31315034"]}, {"Citation": "Alzohairy M.A., Khan A.A., Ansari M.A., Babiker A.Y., Alsahli M.A., Almatroodi S.A., Rahmani A.H. Protective effect of quercetin, a Flavonol against benzo (a) pyrene-induced lung injury via inflammation, oxidative stress, angiogenesis and Cyclooxygenase-2 Signalling molecule. Appl. Sci. 2021;11:8675. doi: 10.3390/app11188675.", "ArticleIdList": ["10.3390/app11188675"]}, {"Citation": "Almatroodi S.A., Almatroudi A., Alsahli M.A., Aljasir M.A., Syed M.A., Rahmani A.H. Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Kr\u00fcpple-Like-Factor 4 (KLF4) Expression. Molecules. 2020;25:2853. doi: 10.3390/molecules25122853.", "ArticleIdList": ["10.3390/molecules25122853", "PMC7356789", "32575718"]}, {"Citation": "Almatroodi S.A., Alnuqaydan A.M., Babiker A.Y., Almogbel M.A., Khan A.A., Husain Rahmani A. 6-Gingerol, a bioactive com-pound of ginger attenuates renal damage in streptozotocin-induced diabetic rats by regulating the oxidative stress and in-flammation. Pharmaceutics. 2021;13:317. doi: 10.3390/pharmaceutics13030317.", "ArticleIdList": ["10.3390/pharmaceutics13030317", "PMC7997342", "33670981"]}, {"Citation": "Rahmani A.H., Alsahli M.A., Khan A.A., Almatroodi S.A. Quercetin, a Plant Flavonol Attenuates Diabetic Complications, Renal Tissue Damage, Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Rats. Metabolites. 2023;13:130. doi: 10.3390/metabo13010130.", "ArticleIdList": ["10.3390/metabo13010130", "PMC9861508", "36677055"]}, {"Citation": "Almatroodi S.A., Khan A.A., Aloliqi A.A., Syed M.A., Rahmani A.H. Therapeutic Potential of Tamarix aphylla in the Prevention of Lung Injury through the Regulation of Inflammation, Oxidative Stress and Cell-Signaling Molecules. Appl. Sci. 2022;12:9925. doi: 10.3390/app12199925.", "ArticleIdList": ["10.3390/app12199925"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Rahmani A.H. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules. 2022;27:5889. doi: 10.3390/molecules27185889.", "ArticleIdList": ["10.3390/molecules27185889", "PMC9505063", "36144625"]}, {"Citation": "Senggunprai L., Tuponchai P., Kukongviriyapan V., Prawan A., Kongpetch S. Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcinoma cells via suppression of STAT3 pathway. J. Cancer Res. Ther. 2019;15:157\u2013163. doi: 10.4103/jcrt.JCRT_287_17.", "ArticleIdList": ["10.4103/jcrt.JCRT_287_17", "30880773"]}, {"Citation": "Zhang M.-J., Su H., Yan J.-Y., Li N., Song Z.-Y., Wang H.-J., Huo L.-G., Wang F., Ji W.-S., Qu X.-J., et al. Chemopreventive effect of Myricetin, a natural occurring compound, on colonic chronic inflammation and inflammation-driven tumorigenesis in mice. Biomed. Pharmacother. 2018;97:1131\u20131137. doi: 10.1016/j.biopha.2017.11.018.", "ArticleIdList": ["10.1016/j.biopha.2017.11.018", "29136951"]}, {"Citation": "Chen H., Lin H., Xie S., Huang B., Qian Y., Chen K., Niu Y., Shen H.-M., Cai J., Li P., et al. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicol. Appl. Pharmacol. 2019;365:19\u201329. doi: 10.1016/j.taap.2018.12.019.", "ArticleIdList": ["10.1016/j.taap.2018.12.019", "30594691"]}, {"Citation": "Li Y., Cui S.-X., Sun S.-Y., Shi W.-N., Song Z.-Y., Wang S.-Q., Yu X.-F., Gao Z.-H., Qu X.-J. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice. Oncotarget. 2016;7:60446\u201360460. doi: 10.18632/oncotarget.11108.", "ArticleIdList": ["10.18632/oncotarget.11108", "PMC5312395", "27507058"]}, {"Citation": "Li T., Zhu J., Deng F., Wu W., Zheng Z., Lv C., Li Y., Xiang W., Lu X., Qin S. Microarray Based Functional Analysis of Myricetin and Proteomic Study on Its Anti-Inflammatory Property. BioMed Res. Int. 2019;2019:3746326. doi: 10.1155/2019/3746326.", "ArticleIdList": ["10.1155/2019/3746326", "PMC6431437", "30956980"]}, {"Citation": "Koff J.L., Ramachandiran S., Bernal-Mizrachi L. A Time to Kill: Targeting Apoptosis in Cancer. Int. J. Mol. Sci. 2015;16:2942\u20132955. doi: 10.3390/ijms16022942.", "ArticleIdList": ["10.3390/ijms16022942", "PMC4346874", "25636036"]}, {"Citation": "Hoshyar R., Mollaei H. A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin. J. Pharm. Pharmacol. 2017;69:1419\u20131427. doi: 10.1111/jphp.12776.", "ArticleIdList": ["10.1111/jphp.12776", "28675431"]}, {"Citation": "Yoon S.Y., Park S.J., Park Y.J. The Anticancer Properties of Cordycepin and Their Underlying Mechanisms. Int. J. Mol. Sci. 2018;19:3027. doi: 10.3390/ijms19103027.", "ArticleIdList": ["10.3390/ijms19103027", "PMC6212910", "30287757"]}, {"Citation": "Zhu M.-L., Zhang P.-M., Jiang M., Yu S.-W., Wang L. Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells. BMC Complement. Med. Ther. 2020;20:209. doi: 10.1186/s12906-020-02965-w.", "ArticleIdList": ["10.1186/s12906-020-02965-w", "PMC7336643", "32631392"]}, {"Citation": "Han S.-H., Lee J.-H., Woo J.-S., Jung G.-H., Jung S.-H., Han E.-J., Kim B., Cho S.D., Nam J.S., Che J.H., et al. Myricetin induces apoptosis and autophagy in human gastric cancer cells through inhibition of the PI3K/Akt/mTOR pathway. Heliyon. 2022;8:e09309. doi: 10.1016/j.heliyon.2022.e09309.", "ArticleIdList": ["10.1016/j.heliyon.2022.e09309", "PMC9065623", "35521506"]}, {"Citation": "Zheng A.-W., Chen Y.-Q., Zhao L.-Q., Feng J.-G. Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells. Oncol. Lett. 2017;13:4974\u20134978. doi: 10.3892/ol.2017.6031.", "ArticleIdList": ["10.3892/ol.2017.6031", "PMC5452908", "28588737"]}, {"Citation": "Ye C., Zhang C., Huang H., Yang B., Xiao G., Kong D., Tian Q., Song Q., Song Y., Tan H., et al. The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 inter-action. Cell. Physiol. Biochem. 2018;48:1230\u20131244. doi: 10.1159/000492009.", "ArticleIdList": ["10.1159/000492009", "30045021"]}, {"Citation": "Yang W., Su J., Li M., Li T., Wang X., Zhao M., Hu X. Myricetin Induces Autophagy and Cell Cycle Arrest of HCC by Inhibiting MARCH1-Regulated Stat3 and p38 MAPK Signaling Pathways. Front. Pharmacol. 2021;12:709526. doi: 10.3389/fphar.2021.709526.", "ArticleIdList": ["10.3389/fphar.2021.709526", "PMC8558373", "34733155"]}, {"Citation": "Rajendran P., Maheshwari U., Muthukrishnan A., Muthuswamy R., Anand K., Ravindran B., Dhanaraj P., Bal-amuralikrishnan B., Chang S.W., Chung W.J. Myricetin: Versatile plant based flavonoid for cancer treatment by inducing cell cycle arrest and ROS\u2013reliant mitochondria-facilitated apoptosis in A549 lung cancer cells and in silico prediction. Mol. Cell. Biochem. 2021;476:57\u201368. doi: 10.1007/s11010-020-03885-6.", "ArticleIdList": ["10.1007/s11010-020-03885-6", "32851589"]}, {"Citation": "Jo S., Ha T.K., Han S.-H., Kim M.E., Jung I., Lee H.-W., Bae S.K., Lee J.S. Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction. Anticancer Res. 2017;37:1705\u20131710. doi: 10.21873/anticanres.11502.", "ArticleIdList": ["10.21873/anticanres.11502", "28373432"]}, {"Citation": "Feng J., Chen X., Wang Y., Du Y., Sun Q., Zang W., Zhao G. Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells. Mol. Cell. Biochem. 2015;408:163\u2013170. doi: 10.1007/s11010-015-2492-1.", "ArticleIdList": ["10.1007/s11010-015-2492-1", "26112905"]}, {"Citation": "Chung A.S., Ferrara N. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 2011;27:563\u2013584. doi: 10.1146/annurev-cellbio-092910-154002.", "ArticleIdList": ["10.1146/annurev-cellbio-092910-154002", "21756109"]}, {"Citation": "Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthritis Res. Ther. 2002;4((Suppl. S3)):S81\u2013S90. doi: 10.1186/ar575.", "ArticleIdList": ["10.1186/ar575", "PMC3240151", "12110126"]}, {"Citation": "Heidenreich R., R\u00f6cken M., Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int. J. Exp. Pathol. 2009;90:232\u2013248. doi: 10.1111/j.1365-2613.2009.00669.x.", "ArticleIdList": ["10.1111/j.1365-2613.2009.00669.x", "PMC2697548", "19563608"]}, {"Citation": "Jung S.K., Lee K.W., Byun S., Lee E.J., Kim J.-E., Bode A.M., Dong Z., Lee H.J. Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo. Carcinogenesis. 2009;31:911\u2013917. doi: 10.1093/carcin/bgp221.", "ArticleIdList": ["10.1093/carcin/bgp221", "PMC2864405", "20008033"]}, {"Citation": "Huang H., Chen A.Y., Rojanasakul Y., Ye X., Rankin G.O., Chen Y.C. Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. J. Funct. Foods. 2015;15:464\u2013475. doi: 10.1016/j.jff.2015.03.051.", "ArticleIdList": ["10.1016/j.jff.2015.03.051", "PMC4476554", "26113875"]}, {"Citation": "Yang C., Lim W., Bazer F.W., Song G. Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress. Cancer Lett. 2017;399:10\u201319. doi: 10.1016/j.canlet.2017.04.014.", "ArticleIdList": ["10.1016/j.canlet.2017.04.014", "28428076"]}, {"Citation": "Yang X., Yang C., Farberman A., Rideout T.C., De Lange C.F.M., France J., Fan M.Z. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2. J. Anim. Sci. 2008;86:E36\u2013E50. doi: 10.2527/jas.2007-0567.", "ArticleIdList": ["10.2527/jas.2007-0567", "17998426"]}, {"Citation": "Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926\u20131945. doi: 10.1101/gad.1212704.", "ArticleIdList": ["10.1101/gad.1212704", "15314020"]}, {"Citation": "Hanrahan J., Blenis J. Rheb Activation of mTOR and S6K1 Signaling. Methods Enzymol. 2006;407:542\u2013555. doi: 10.1016/s0076-6879(05)07044-8.", "ArticleIdList": ["10.1016/s0076-6879(05)07044-8", "16757352"]}, {"Citation": "Yuan T.L., Cantley L.C. PI3K pathway alterations in cancer: Variations on a theme. Oncogene. 2008;27:5497\u20135510. doi: 10.1038/onc.2008.245.", "ArticleIdList": ["10.1038/onc.2008.245", "PMC3398461", "18794884"]}, {"Citation": "Zwolak P., Borja-Cacho D., Phillips P.A., Dudeja V., Dawra R., Ankeny J.S., Talukdar R., Chugh R., Vickers S., Saluja A. Myricetin induces apoptosis via caspase activation and inhibition of pi-3 kinase/akt and erk pathways in human pancreatic cells. Pancreas. 2007;35:439. doi: 10.1097/01.mpa.0000297824.52312.fa.", "ArticleIdList": ["10.1097/01.mpa.0000297824.52312.fa"]}, {"Citation": "Kim G.D. Myricetin Inhibits Angiogenesis by Inducing Apoptosis and Suppressing PI3K/Akt/mTOR Signaling in Endothelial Cells. J. Cancer Prev. 2017;22:219\u2013227. doi: 10.15430/JCP.2017.22.4.219.", "ArticleIdList": ["10.15430/JCP.2017.22.4.219", "PMC5751839", "29302579"]}, {"Citation": "Sharma P., Khan M.A., Najmi A.K., Chaturvedi S., Akhtar M. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway. Med. Oncol. 2022;39:248. doi: 10.1007/s12032-022-01856-z.", "ArticleIdList": ["10.1007/s12032-022-01856-z", "36209343"]}, {"Citation": "Chen C., Gao H., Su X. Autophagy-related signaling pathways are involved in cancer (Review) Exp. Ther. Med. 2021;22:710. doi: 10.3892/etm.2021.10142.", "ArticleIdList": ["10.3892/etm.2021.10142", "PMC8120650", "34007319"]}, {"Citation": "Ji A., Hu L., Ma D., Qiang G., Yan D., Zhang G., Jiang C. Myricetin induces apoptosis and protective autophagy through endo-plasmic reticulum stress in hepatocellular carcinoma. Evid.-Based Complement. Altern. Med. 2022;2022:3115312. doi: 10.1155/2022/3115312.", "ArticleIdList": ["10.1155/2022/3115312", "PMC9168098", "35677365"]}, {"Citation": "Cao J., Chen H., Lu W., Wu Y., Wu X., Xia D., Zhu J. Myricetin Induces Protective Autophagy by Inhibiting the Phosphorylation of mTOR in HepG2 Cells. Anat. Rec. 2017;301:786\u2013795. doi: 10.1002/ar.23754.", "ArticleIdList": ["10.1002/ar.23754", "29244256"]}, {"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Liu J.S., Fang W.K., Yang S.M., Wu M.C., Chen T.J., Chen C.M., Lin T.Y., Liu K.L., Wu C.M., Chen Y.C., et al. Natural product my-ricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer. J. Biomed. Sci. 2022;29:29. doi: 10.1186/s12929-022-00812-3.", "ArticleIdList": ["10.1186/s12929-022-00812-3", "PMC9082844", "35534851"]}, {"Citation": "Keum N., Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat. Rev. Gastroenterol. Hepatol. 2019;16:713\u2013732. doi: 10.1038/s41575-019-0189-8.", "ArticleIdList": ["10.1038/s41575-019-0189-8", "31455888"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Kim M.E., Ha T.K., Yoon J.H., Lee J.S. Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer Res. 2014;34:701\u2013706.", "ArticleIdList": ["24511002"]}, {"Citation": "Lee J.H., Choi Y.J., Park S.-H., Nam M.J. Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15 cells. Food Chem. Toxicol. 2018;116:315\u2013322. doi: 10.1016/j.fct.2018.04.053.", "ArticleIdList": ["10.1016/j.fct.2018.04.053", "29698783"]}, {"Citation": "Alidadi H., Ashtari A., Samimi A., Karami M.A., Khorsandi L. Myricetin loaded in solid lipid nanoparticles induces apoptosis in the HT-29 colorectal cancer cells via mitochondrial dysfunction. Mol. Biol. Rep. 2022;49:8537\u20138545. doi: 10.1007/s11033-022-07683-9.", "ArticleIdList": ["10.1007/s11033-022-07683-9", "35767106"]}, {"Citation": "Li M., Chen J., Yu X., Xu S., Li D., Zheng Q., Yin Y. Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP. Cells. 2019;8:358. doi: 10.3390/cells8040358.", "ArticleIdList": ["10.3390/cells8040358", "PMC6523269", "30999669"]}, {"Citation": "Ma H., Zhu L., Ren J., Rao B., Sha M., Kuang Y., Shen W., Xu Z. Myricetin inhibits migration and invasion of hepatocellular car-cinoma MHCC97H cell line by inhibiting the EMT process. Oncol. Lett. 2019;18:6614\u20136620.", "ArticleIdList": ["PMC6865832", "31788118"]}, {"Citation": "Phillips P., Sangwan V., Borja-Cacho D., Dudeja V., Vickers S., Saluja A. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett. 2011;308:181\u2013188. doi: 10.1016/j.canlet.2011.05.002.", "ArticleIdList": ["10.1016/j.canlet.2011.05.002", "PMC3126884", "21676539"]}, {"Citation": "Valle J.W., Kelley R.K., Nervi B., Oh D.Y., Zhu A.X. Biliary tract cancer. Lancet. 2021;397:428\u2013444. doi: 10.1016/S0140-6736(21)00153-7.", "ArticleIdList": ["10.1016/S0140-6736(21)00153-7", "33516341"]}, {"Citation": "Wang L., Feng J., Chen X., Guo W., Du Y., Wang Y., Zang W., Zhang S., Zhao G. Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell Int. 2014;14:71. doi: 10.1186/s12935-014-0071-2.", "ArticleIdList": ["10.1186/s12935-014-0071-2", "PMC4364039", "25788859"]}, {"Citation": "Zang W., Wang T., Wang Y., Li M., Xuan X., Ma Y., Du Y., Liu K., Dong Z., Zhao G. Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2. Tumor Biol. 2014;35:12583\u201312592. doi: 10.1007/s13277-014-2579-4.", "ArticleIdList": ["10.1007/s13277-014-2579-4", "25192723"]}, {"Citation": "Li Q., Tan Q., Ma Y., Gu Z., Chen S. Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress. Front. Oncol. 2022;12:903394. doi: 10.3389/fonc.2022.903394.", "ArticleIdList": ["10.3389/fonc.2022.903394", "PMC9130763", "35646711"]}, {"Citation": "Xu Y., Xie Q., Wu S., Yi D., Yu Y., Liu S., Li S., Li Z. Myricetin induces apoptosis via endoplasmic reticulum stress and DNA dou-ble-strand breaks in human ovarian cancer cells. Mol. Med. Rep. 2016;13:2094\u20132100. doi: 10.3892/mmr.2016.4763.", "ArticleIdList": ["10.3892/mmr.2016.4763", "PMC4768956", "26782830"]}, {"Citation": "Sajedi N., Homayoun M., Mohammadi F., Soleimani M. Myricetin Exerts its Apoptotic Effects on MCF-7 Breast Cancer Cells through Evoking the BRCA1-GADD45 Pathway. Asian Pac. J. Cancer Prev. 2020;21:3461\u20133468. doi: 10.31557/APJCP.2020.21.12.3461.", "ArticleIdList": ["10.31557/APJCP.2020.21.12.3461", "PMC8046300", "33369440"]}, {"Citation": "Knickle A., Fernando W., Greenshields A.L., Rupasinghe H.V., Hoskin D.W. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide. Food Chem. Toxicol. 2018;118:154\u2013167. doi: 10.1016/j.fct.2018.05.005.", "ArticleIdList": ["10.1016/j.fct.2018.05.005", "29742465"]}, {"Citation": "Jayakumar J.K., Nirmala P., Kumar B.A.P., Kumar A.P. Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats. South Asian J. Cancer. 2014;3:107\u2013111. doi: 10.4103/2278-330X.130443.", "ArticleIdList": ["10.4103/2278-330X.130443", "PMC4014640", "24818105"]}, {"Citation": "Han S.H., Lee J.H., Woo J.S., Jung G.H., Jung S.H., Han E.J., Park Y.S., Kim B.S., Kim S.K., Park B.K., et al. Myricetin induces apoptosis through the MAPK pathway and regulates JNK mediated autophagy in SK BR 3 cells. Int. J. Mol. Med. 2022;49:54. doi: 10.3892/ijmm.2022.5110.", "ArticleIdList": ["10.3892/ijmm.2022.5110", "PMC8904074", "35234274"]}, {"Citation": "Yi J.-L., Shi S., Shen Y.-L., Wang L., Chen H.-Y., Zhu J., Ding Y. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int. J. Clin. Exp. Pathol. 2015;8:1116\u20131127.", "ArticleIdList": ["PMC4396221", "25972998"]}, {"Citation": "Chen Y.C., He X.L., Qi L., Shi W., Yuan L.W., Huang M.Y., Xu Y.L., Chen X., Gu L., Zhang L.L., et al. Myricetin inhibits interfer-on-\u03b3-induced PD-L1 and IDO1 expression in lung cancer cells. Biochem. Pharmacol. 2022;197:114940. doi: 10.1016/j.bcp.2022.114940.", "ArticleIdList": ["10.1016/j.bcp.2022.114940", "35120895"]}, {"Citation": "Li M., Zha G., Chen R., Chen X., Sun Q., Jiang H. Anticancer effects of myricetin derivatives in non-small cell lung cancer in vitro and in vivo. Pharmacol. Res. Perspect. 2022;10:e00905. doi: 10.1002/prp2.905.", "ArticleIdList": ["10.1002/prp2.905", "PMC8929361", "34964301"]}, {"Citation": "Han J., Cheng C., Zhang J., Fang J., Yao W., Zhu Y., Xiu Z., Jin N., Lu H., Li X., et al. Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells. Front. Pharmacol. 2022;13:959938. doi: 10.3389/fphar.2022.959938.", "ArticleIdList": ["10.3389/fphar.2022.959938", "PMC9458876", "36091790"]}, {"Citation": "Kang H.R., Moon J.Y., Ediriweera M.K., Song Y.W., Cho M., Kasiviswanathan D., Cho S.K. Dietary flavonoid myricetin inhibits invasion and migration of radioresistant lung cancer cells (A549-IR) by suppressing MMP-2 and MMP-9 expressions through inhibition of the FAK-ERK signaling pathway. Food Sci. Nutr. 2020;8:2059\u20132067. doi: 10.1002/fsn3.1495.", "ArticleIdList": ["10.1002/fsn3.1495", "PMC7174229", "32328272"]}, {"Citation": "Zhang S., Wang L., Liu H., Zhao G., Ming L. Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells. Diagn. Pathol. 2014;9:68. doi: 10.1186/1746-1596-9-68.", "ArticleIdList": ["10.1186/1746-1596-9-68", "PMC3994494", "24650056"]}, {"Citation": "Maggioni D., Nicolini G., Rigolio R., Biffi L., Pignataro L., Gaini R., Garavello W. Myricetin and Naringenin Inhibit Human Squamous Cell Carcinoma Proliferation and Migration In Vitro. Nutr. Cancer. 2014;66:1257\u20131267. doi: 10.1080/01635581.2014.951732.", "ArticleIdList": ["10.1080/01635581.2014.951732", "25256786"]}, {"Citation": "Song X., Rao H., Guo C., Yang B., Ren Y., Wang M., Li Y., Cao Z., Pei J. Myricetin exhibit selective anti-lymphoma activity by tar-geting BTK and is effective via oral administration in vivo. Phytomedicine. 2021;93:153802. doi: 10.1016/j.phymed.2021.153802.", "ArticleIdList": ["10.1016/j.phymed.2021.153802", "34710755"]}, {"Citation": "Pan H., Hu Q., Wang J., Liu Z., Wu D., Lu W., Huang J. Myricetin is a novel inhibitor of human inosine 5\u2032-monophosphate de-hydrogenase with anti-leukemia activity. Biochem. Biophys. Res. Commun. 2016;477:915\u2013922. doi: 10.1016/j.bbrc.2016.06.158.", "ArticleIdList": ["10.1016/j.bbrc.2016.06.158", "27378425"]}, {"Citation": "Dimas K., Demetzos C., Angelopoulou D., Kolokouris A., Mavromoustakos T. Biological activity of myricetin and its derivatives against human leukemic cell lines in vitro. Pharmacol. Res. 2000;42:475\u2013478. doi: 10.1006/phrs.2000.0716.", "ArticleIdList": ["10.1006/phrs.2000.0716", "11023711"]}, {"Citation": "Sun F., Zheng X.Y., Ye J., Wu T.T., Wang J.L., Chen W. Potential Anticancer Activity of Myricetin in Human T24 Bladder Cancer Cells Both In Vitro and In Vivo. Nutr. Cancer. 2012;64:599\u2013606. doi: 10.1080/01635581.2012.665564.", "ArticleIdList": ["10.1080/01635581.2012.665564", "22482362"]}, {"Citation": "Ha T.K., Jung I., Kim M.E., Bae S.K., Lee J.S. Anti-cancer activity of myricetin against human papillary thyroid cancer cells involves mitochondrial dysfunction\u2013mediated apoptosis. Biomed. Pharmacother. 2017;91:378\u2013384. doi: 10.1016/j.biopha.2017.04.100.", "ArticleIdList": ["10.1016/j.biopha.2017.04.100", "28463801"]}, {"Citation": "Park H., Park S., Bazer F.W., Lim W., Song G. Myricetin treatment induces apoptosis in canine osteosarcoma cells by inducing DNA fragmentation, disrupting redox homeostasis, and mediating loss of mitochondrial membrane potential. J. Cell. Physiol. 2018;233:7457\u20137466. doi: 10.1002/jcp.26598.", "ArticleIdList": ["10.1002/jcp.26598", "29663365"]}, {"Citation": "Jung S.K., Lee K.W., Byun S., Kang N.J., Lim S.H., Heo Y.-S., Bode A.M., Bowden G.T., Lee H.J., Dong Z. Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn. Cancer Res. 2008;68:6021\u20136029. doi: 10.1158/0008-5472.CAN-08-0899.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-0899", "18632659"]}, {"Citation": "Sun W., Tao Y., Yu D., Zhao T., Wu L., Yu W., Han W. Myricetin exerts potent anticancer effects on human skin tumor cells. Trop. J. Pharm. Res. 2018;17:1067. doi: 10.4314/tjpr.v17i6.13.", "ArticleIdList": ["10.4314/tjpr.v17i6.13"]}, {"Citation": "Akhtar S., Najafzadeh M., Isreb M., Newton L., Gopalan R.C., Anderson D. Anticancer potential of myricetin bulk and nano forms in vitro in lymphocytes from myeloma patients. Arch. Toxicol. 2021;95:337\u2013343. doi: 10.1007/s00204-020-02938-5.", "ArticleIdList": ["10.1007/s00204-020-02938-5", "PMC7811500", "33128380"]}, {"Citation": "Li H.G., Chen J.X., Xiong J.H., Zhu J.W. Myricetin exhibits anti-glioma potential by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of cell migration and ROS generation. J. BUON. 2016;21:182\u2013190.", "ArticleIdList": ["27061547"]}, {"Citation": "Siegelin M., Gaiser T., Habel A., Siegelin Y. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Cancer Lett. 2009;283:230\u2013238. doi: 10.1016/j.canlet.2009.04.002.", "ArticleIdList": ["10.1016/j.canlet.2009.04.002", "19398149"]}, {"Citation": "Dang Y., Lin G., Xie Y., Duan J., Ma P., Li G., Ji G. Quantitative Determination of Myricetin in Rat Plasma by Ultra Performance Liquid Chromatography Tandem Mass Spectrometry and its Absolute Bioavailability. Drug Res. 2014;64:516\u2013522. doi: 10.1055/s-0033-1363220.", "ArticleIdList": ["10.1055/s-0033-1363220", "24357136"]}, {"Citation": "Lin Y., Wu B., Li Z., Hong T., Chen M., Tan Y., Jiang J., Huang C. Metabolite Identification of Myricetin in Rats Using HPLC Coupled with ESI-MS. Chromatographia. 2012;75:655\u2013660. doi: 10.1007/s10337-012-2239-z.", "ArticleIdList": ["10.1007/s10337-012-2239-z"]}, {"Citation": "Choi D.-H., Li C., Choi J.-S. Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: Possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin. J. Pharm. Pharmacol. 2010;62:908\u2013914. doi: 10.1211/jpp.62.07.0012.", "ArticleIdList": ["10.1211/jpp.62.07.0012", "20636879"]}, {"Citation": "Wang G., Wang J.-J., Tang X.-J., Du L., Li F. In vitro and in vivo evaluation of functionalized chitosan\u2013Pluronic micelles loaded with myricetin on glioblastoma cancer. Nanomed. Nanotechnol. Biol. Med. 2016;12:1263\u20131278. doi: 10.1016/j.nano.2016.02.004.", "ArticleIdList": ["10.1016/j.nano.2016.02.004", "26970027"]}, {"Citation": "Song Y., Zhou B., Du X., Wang Y., Zhang J., Ai Y., Xia Z., Zhao G. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC) Biomed. Pharmacother. 2020;125:109561. doi: 10.1016/j.biopha.2019.109561.", "ArticleIdList": ["10.1016/j.biopha.2019.109561", "32106385"]}, {"Citation": "Maroufi N.F., Vahedian V., Mazrakhondi S.A., Kooti W., Khiavy H.A., Bazzaz R., Ramezani F., Pirouzpanah S.M., Ghorbani M., Akbarzadeh M., et al. Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocom-patible lipid nanoparticles via sub-G1 cell cycle arrest mechanism. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2020;393:1\u201311. doi: 10.1007/s00210-019-01692-5.", "ArticleIdList": ["10.1007/s00210-019-01692-5", "31372697"]}, {"Citation": "Nafee N., Gaber D.M., Elzoghby A.O., Helmy M.W., Abdallah O.Y. Promoted antitumor activity of myricetin against lung carci-noma via nanoencapsulated phospholipid complex in respirable microparticles. Pharm. Res. 2020;37:82. doi: 10.1007/s11095-020-02794-z.", "ArticleIdList": ["10.1007/s11095-020-02794-z", "32291520"]}, {"Citation": "Mohan U.P., Sriram B., Panneerselvam T., Devaraj S., MubarakAli D., Parasuraman P., Palanisamy P., Premanand A., Arunachalam S., Kunjiappan S. Utilization of plant-derived Myricetin molecule coupled with ultrasound for the synthesis of gold nanopar-ticles against breast cancer. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2020;393:1963\u20131976. doi: 10.1007/s00210-020-01874-6.", "ArticleIdList": ["10.1007/s00210-020-01874-6", "32468137"]}, {"Citation": "Kunjiappan S., Govindaraj S., Parasuraman P., Sankaranarayanan M., Arunachalam S., Palanisamy P., Mohan U.P., Babkiewicz E., Maszczyk P., Vellaisamy S., et al. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment. Nanotechnology. 2020;31:155102. doi: 10.1088/1361-6528/ab5c56.", "ArticleIdList": ["10.1088/1361-6528/ab5c56", "31775133"]}, {"Citation": "Zhou H., Xu L., Shi Y., Gu S., Wu N., Liu F., Huang Y., Qian Z., Xue W., Wang X., et al. A Novel Myricetin Derivative with Anti-cancer Properties Induces Cell Cycle Arrest and Apoptosis in A549 Cells. Biol. Pharm. Bull. 2023;46:42\u201351. doi: 10.1248/bpb.b22-00483.", "ArticleIdList": ["10.1248/bpb.b22-00483", "36596525"]}, {"Citation": "Wang F., Song Z.-Y., Qu X.-J., Li F., Zhang L., Li W.-B., Cui S.-X. M10, a novel derivative of Myricetin, prevents ulcerative colitis and colorectal tumor through attenuating robust endoplasmic reticulum stress. Carcinogenesis. 2018;39:889\u2013899. doi: 10.1093/carcin/bgy057.", "ArticleIdList": ["10.1093/carcin/bgy057", "29757351"]}, {"Citation": "Morales P., Haza A.I. Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J. Appl. Toxicol. 2011;32:986\u2013993. doi: 10.1002/jat.1725.", "ArticleIdList": ["10.1002/jat.1725", "21935971"]}, {"Citation": "Zhang J., Aray B., Zhang Y., Bai Y., Yuan T., Ding S., Xue Y., Huang X., Li Z. Synergistic effect of cucurbitacin E and myricetin on Anti-Non-Small cell lung cancer: Molecular mechanism and therapeutic potential. Phytomedicine. 2023;111:154619. doi: 10.1016/j.phymed.2022.154619.", "ArticleIdList": ["10.1016/j.phymed.2022.154619", "36706697"]}, {"Citation": "Yang Y., Choi J.K., Jung C.H., Koh H.J., Heo P., Shin J.Y., Kim S., Park W.-S., Shin H.-J., Kweon D.-H. SNARE-Wedging Polyphenols as Small Molecular Botox. Planta Med. 2012;78:233\u2013236. doi: 10.1055/s-0031-1280385.", "ArticleIdList": ["10.1055/s-0031-1280385", "22109835"]}, {"Citation": "Kim J.D., Liu L., Guo W., Meydani M. Chemical structure of flavonols in relation to modulation of angiogenesis and im-mune-endothelial cell adhesion. J. Nutr. Biochem. 2006;17:165\u2013176. doi: 10.1016/j.jnutbio.2005.06.006.", "ArticleIdList": ["10.1016/j.jnutbio.2005.06.006", "16169200"]}, {"Citation": "Canada A.T., Watkins W., Nguyen T.D. The toxicity of flavonoids to guinea pig enterocytes. Toxicol. Appl. Pharmacol. 1989;99:357\u2013361. doi: 10.1016/0041-008X(89)90018-5.", "ArticleIdList": ["10.1016/0041-008X(89)90018-5", "2734797"]}, {"Citation": "Canada A.T., Giannella E., Nguyen T.D., Mason R.P. The production of reactive oxygen species by dietary flavonols. Free Radic. Biol. Med. 1990;9:441\u2013449. doi: 10.1016/0891-5849(90)90022-B.", "ArticleIdList": ["10.1016/0891-5849(90)90022-B", "1963417"]}, {"Citation": "Javed Z., Khan K., Herrera-Bravo J., Naeem S., Iqbal M.J., Raza Q., Sadia H., Raza S., Bhinder M., Calina D., et al. Myricetin: Targeting signaling networks in cancer and its implication in chemotherapy. Cancer Cell Int. 2022;22:239. doi: 10.1186/s12935-022-02663-2.", "ArticleIdList": ["10.1186/s12935-022-02663-2", "PMC9336020", "35902860"]}, {"Citation": "Sharma T., Singh D., Mahapatra A., Mohapatra P., Sahoo S., Sahoo S.K. Advancements in clinical translation of flavonoid na-noparticles for cancer treatment. OpenNano. 2022;8:100074. doi: 10.1016/j.onano.2022.100074.", "ArticleIdList": ["10.1016/j.onano.2022.100074"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "19"}, {"Year": "2023", "Month": "5", "Day": "27"}, {"Year": "2023", "Month": "5", "Day": "30"}, {"Year": "2023", "Month": "6", "Day": "12", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "10", "Hour": "15", "Minute": "14"}, {"Year": "2023", "Month": "6", "Day": "10", "Hour": "1", "Minute": "13"}, {"Year": "2023", "Month": "6", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["37298616", "PMC10253333", "10.3390/ijms24119665", "ijms24119665"]}}], "PubmedBookArticle": []}